Our complementary asset classes offer a unique investment platform.
TPG Capital is TPG's principal investment platform in the U.S., Europe, Asia, Australia and Latin America, and generally focuses on established businesses that require equity capital between $10 million and $1 billion. Investments in companies through acquisitions and restructurings span a broad range of industries including financial services, travel and entertainment, technology, retail, consumer products, healthcare, and media and communications. TPG Capital has had lead responsibility for more than 140 transactions, investing approximately $31.1 billion of equity capital across a number of economic and credit cycles.
TPG Growth is TPG's platform for smaller buyouts and growth equity investments globally. TPG Growth invests in a broad range of industries including consumer, retail, technology, internet, healthcare, energy, cleantech and renewables, transportation, industrials, and business services. TPG Growth utilizes a broad range of investment structures including leverage buyouts, growth equity, and private investment in public equities (PIPE's), and leverages the broader platform of TPG Capital.
TPG Biotech is TPG's life science venture capital platform, supporting physicians, scientists and entrepreneurs who are building innovation-based businesses.
TPG Opportunities Partners is TPG's platform for pursuing actively managed credit-related investment opportunities. Through this platform, TPG seeks to purchase or originate special situations/distressed investments across the credit cycle by targeting deep value opportunities that are difficult to source, analyze, or execute.
TPG Specialty Lending is a specialty finance investment company focused on middle market lending and is managed through the TPG Opportunities Partners platform. Securities law filings by TSL may be found at www.sec.gov.
Click here for information on certain other strategic relationships.